Porphyrin-Engineered 125 I-Nanoseeds as a Prototype for Immunogenic Brachytherapy
Journal of the American Chemical Society · 2025
DOI: 10.1021/jacs.4c17573 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Zhiyu Tu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, Radiochemistry and Radiation Chemistry, Key Laboratory of Fundamental Science, Key Laboratory of …. Hauptthemen laut MEDLINE: Brachytherapy, Iodine Radioisotopes, Porphyrins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Beijing National Laboratory for Molecular Sciences, Radiochemistry and Radiation Chemistry, Key Laboratory of Fundamental Science, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Educatio…
- Changping Laboratory, Beijing 102206, China.
- Peking University-Tsinghua University Center for Life Sciences, Peking University, Beijing 100871, China.
- Department of Head and Neck Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
- Cancer Center, Peking University Third Hospital, Beijing 100191, China.
- Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China.
ORCID-Profile: Zhibo Liu
Förderung
- Ministry of Science and Technology of the People's Republic of China
- Natural Science Foundation of Beijing Municipality
- National Natural Science Foundation of China
- Changping Laboratory
Zitieren
APA
Tu, Z., Sang, Z., Xu, Y., Liang, W., Qiao, S., Sun, Q., Feng, K., Kong, Z., Wang, H., & Liu, Z. (2025). Porphyrin-Engineered 125 I-Nanoseeds as a Prototype for Immunogenic Brachytherapy. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.4c17573
Vancouver
Tu Z, Sang Z, Xu Y, Liang W, Qiao S, Sun Q, et al. Porphyrin-Engineered 125 I-Nanoseeds as a Prototype for Immunogenic Brachytherapy. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.4c17573
BibTeX
@article{Tu2025,
author = {Tu, Zhiyu and Sang, Ziyang and Xu, Yang and Liang, Weiqiu and Qiao, Simiao and Sun, Qi and Feng, Kongchang and Kong, Ziren and Wang, Hao and Liu, Zhibo},
title = {Porphyrin-Engineered 125 I-Nanoseeds as a Prototype for Immunogenic Brachytherapy},
journal = {Journal of the American Chemical Society},
year = {2025},
doi = {10.1021/jacs.4c17573}
}
EUVIMED